Finance

Bitmine's Ethereum Acquisition Nears Key Threshold as Stock Holds Crucial Support

Bitmine expands crypto holdings while its stock tests significant resistance and support levels amid optimistic staking revenue prospects

Bitmine Immersion Technologies Inc. has bolstered its Ethereum holdings by acquiring an additional 32,977 ETH, amounting to a total of 4.144 million E...

Qualcomm Advances Its Edge Computing and Automotive Tech at CES 2026

Strategic acquisitions and partnerships position Qualcomm as a key player in IoT, robotics, and next-generation automotive solutions

At CES 2026, Qualcomm showcased its expanding role as a comprehensive provider of integrated technologies for the Internet of Things, robotics, and au...

Venezuela Operation Spurs Rally in Drone Technology Stocks

Market Response Highlights Strategic Role of Unmanned Aerial Systems in Urban Combat

The recent U.S. operation resulting in the capture of Venezuela's President Nicolás Maduro has significantly influenced market dynamics, particularly...

Incyte Reports Positive Phase 3 Trial Data for Tafasitamab Combination in First-Line DLBCL Treatment

Phase 3 frontMIND study shows improved progression-free and event-free survival with tafasitamab plus lenalidomide added to R-CHOP regimen

Incyte Corporation unveiled encouraging results from the Phase 3 frontMIND clinical trial evaluating the addition of tafasitamab and lenalidomide to t...

Raoul Pal Projects Surge in Bitcoin Value Driven by $8 Trillion Liquidity Injection in 2026

Macro investor outlines liquidity-led rebound and the rising prominence of smart contract platforms in the crypto space

Bitcoin stands poised for a significant upswing as macroeconomic liquidity injections totaling up to $8 trillion are anticipated over the next year, a...

Mark Cuban Highlights Dual Failures of US Healthcare System from Personal Perspective

From financial barriers to full-pay access, Cuban underscores systemic inefficiencies and lack of transparency

Billionaire entrepreneur Mark Cuban shared his personal experiences with the American healthcare system, emphasizing that it fails both the uninsured ...

L3Harris Advances Space Propulsion Segment Restructuring Through Strategic Sale to AE Industrial Partners

The transaction enables L3Harris to maintain a significant stake while transferring operational control of a prominent U.S. propulsion business

L3Harris Technologies has agreed to transfer a controlling interest in its Space Propulsion and Power Systems division to AE Industrial Partners. The ...

Datavault AI Announces Nationwide Expansion of SanQtum Platform, Driving Stock Gains

Strategic partnership with AP Global Holdings LLC to enhance secure data processing across 100 U.S. cities

Datavault AI Inc. reported a substantial rise in its stock price following its announcement of a comprehensive deployment of its SanQtum platform. Par...

Bitcoin Climbs to $94,000 Amid Venezuela's Geopolitical Challenges

On-chain data reveals steady investor confidence despite turmoil in Venezuela’s political landscape

Bitcoin prices surged to $94,000 on Monday, showing resilience even as Venezuela faces significant geopolitical unrest. Analysis of on-chain metrics i...

Neumora Therapeutics Advances Alzheimer’s Agitation Drug, Shares Rise

Promising Phase 1b Results for NMRA-511 Propel Development Plans Forward

Neumora Therapeutics reported positive outcomes from its Phase 1b trial of NMRA-511, targeting agitation associated with Alzheimer's disease, demonstr...

Altimmune Shares Surge Following FDA Breakthrough Therapy Designation for Pemvidutide

The FDA’s expedited approval process for Altimmune’s liver disease treatment fuels investor interest

Altimmune, Inc. has experienced a significant increase in its stock value after the U.S. Food and Drug Administration granted Breakthrough Therapy Des...

Crinetics Pharmaceuticals Shares Surge Following Encouraging Phase 2 Trial Results for Atumelnant in CAH Treatment

Company reports robust hormone control and glucocorticoid dose reduction in congenital adrenal hyperplasia patients, alongside positive product launch and pipeline developments

Crinetics Pharmaceuticals experienced a notable increase in stock value after unveiling promising outcomes from the fourth cohort of its Phase 2 study...